Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Shin BH et al. |
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. |
2014 |
Transplantation |
pmid:24342979
|
First MR and Fitzsimmons WE |
New drugs to improve transplant outcomes. |
2004 |
Transplantation |
pmid:15201693
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Yoon SH et al. |
CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). |
2013 |
Transplantation |
pmid:23364483
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Ravindran VK et al. |
Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. |
2009 |
Transplantation |
pmid:19543067
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Butani L et al. |
Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. |
2003 |
Transplantation |
pmid:12883183
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation. |
2017 |
Transplantation |
pmid:27482958
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. |
2006 |
Transplantation |
pmid:16570006
|
Reddy KS et al. |
Simultaneous kidney-pancreas transplantation without antilymphocyte induction. |
2000 |
Transplantation |
pmid:10653379
|
Sood P et al. |
Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. |
2012 |
Transplantation |
pmid:23018881
|
Jevnikar A et al. |
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure. |
2008 |
Transplantation |
pmid:18852662
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Naesens M and Sarwal MM |
Monitoring calcineurin inhibitor therapy: localizing the moving target. |
2010 |
Transplantation |
pmid:20458272
|
Watson MJ et al. |
Renal function impacts outcomes after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622288
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
Amundsen R et al. |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. |
2009 |
Transplantation |
pmid:19384170
|
Jun KR et al. |
Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. |
2009 |
Transplantation |
pmid:19384171
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Ji E et al. |
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. |
2012 |
Transplantation |
pmid:22992768
|
Hu H et al. |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. |
2003 |
Transplantation |
pmid:12698107
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Fujishiro J et al. |
Immunologic benefits of longer graft in rat allogenic small bowel transplantation. |
2005 |
Transplantation |
pmid:15665767
|
Thai NL et al. |
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. |
2006 |
Transplantation |
pmid:17198247
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Hewitt CW and Black KS |
Comparative studies of FK506 with cyclosporine. |
1988 |
Transplantation |
pmid:2458644
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Rezeig MA et al. |
Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. |
1997 |
Transplantation |
pmid:9175820
|
Vadivel N et al. |
Tacrolimus dose in black renal transplant recipients. |
2007 |
Transplantation |
pmid:17460575
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|
Swanson C et al. |
FK 506-based immunosuppression in clinical pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539827
|
Kobayashi N et al. |
Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation. |
1991 |
Transplant. Proc. |
pmid:1703707
|
Fougeray S et al. |
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers. |
2011 |
Transplant. Proc. |
pmid:22099811
|
Tang J et al. |
Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27788813
|
Neylan JF |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636551
|
Tanabe K et al. |
ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119903
|
Elmer DS et al. |
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. |
1998 |
Transplant. Proc. |
pmid:9532159
|
Berman M et al. |
Lipid metabolism and immunosuppressive therapy in heart transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12644091
|
Fukushima N et al. |
Histological findings in heart grafts after orthotopic pig to baboon cardiac transplantation. |
1996 |
Transplant. Proc. |
pmid:8623400
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Yamaguchi M et al. |
FK 506 significantly improves transferred insulin gene expression in total pancreatectomized dogs. |
2000 |
Transplant. Proc. |
pmid:11120255
|
Morales JM et al. |
Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. |
1999 |
Transplant. Proc. |
pmid:10576051
|
Mano A et al. |
Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report. |
2009 |
Transplant. Proc. |
pmid:19917396
|
Lampreabe I et al. |
Toward personalized medicine in renal transplantation. |
2010 |
Transplant. Proc. |
pmid:20970553
|
Sato K et al. |
Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249521
|
Nishimori H et al. |
Combination therapy with FK 506 and splenectomy may induce tolerance in cardiac xenografts. |
1994 |
Transplant. Proc. |
pmid:7518102
|
Yasuhara M et al. |
Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. |
1995 |
Transplant. Proc. |
pmid:7533356
|
Su MS and Semerjian A |
Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner. |
1991 |
Transplant. Proc. |
pmid:1721310
|
Dammeijer PF et al. |
Combined effect of low-dose FK 506 and cyclosporine A on skin graft survival. |
1990 |
Transplant. Proc. |
pmid:1697116
|
Suga A et al. |
Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12591391
|
Koefoed-Nielsen PB et al. |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. |
2005 |
Transplant. Proc. |
pmid:15919449
|
Tamura K et al. |
Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. |
1995 |
Transplant. Proc. |
pmid:7533409
|
Uemoto S et al. |
Experience with FK 506 in living related donor liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721342
|
Aguirrezabalaga J et al. |
Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin. |
2002 |
Transplant. Proc. |
pmid:12176480
|
Gerauer K et al. |
Long-term cardiac allograft survival in mice treated with malononitrilamide 715. |
1998 |
Transplant. Proc. |
pmid:9865349
|
Hossain MA et al. |
Immunosuppression in auxiliary partial liver transplantation with FK506 in rats. |
1997 |
Transplant. Proc. |
pmid:9414861
|
Parada MT et al. |
Everolimus in lung transplantation in Chile. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172343
|
Weimer R et al. |
Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study. |
2002 |
Transplant. Proc. |
pmid:12270445
|
Oltean M et al. |
FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. |
2005 |
Transplant. Proc. |
pmid:15919508
|
Jordan ML et al. |
Five-year experience with tacrolimus rescue for renal allograft rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123009
|
Fahlke J et al. |
Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study. |
2002 |
Transplant. Proc. |
pmid:12072328
|
Yamada T et al. |
Synergistic effect of FK 506 and trifluoperazine on the immunosuppression in rat small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907927
|
Uchida K et al. |
Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan. |
2002 |
Transplant. Proc. |
pmid:12176503
|
Calia R et al. |
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620041
|
Nakata S et al. |
Immunosuppressive mechanisms of deoxymethylspergualin and FK 506 on in vitro cytotoxic T lymphocytes. |
1994 |
Transplant. Proc. |
pmid:7520613
|
|
Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721374
|
Christians U et al. |
Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. |
1991 |
Transplant. Proc. |
pmid:1703358
|
Humar A et al. |
Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083256
|
Grochowicz PM et al. |
Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123296
|
Gerbase MW et al. |
Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. |
2001 |
Transplant. Proc. |
pmid:11377481
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Sifontis NM et al. |
Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176554
|
Lee PC et al. |
Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept? |
2012 |
Transplant. Proc. |
pmid:22310598
|
Adams CK and Famili P |
A study of the effects of the drug FK 506 on gingival tissues. |
1991 |
Transplant. Proc. |
pmid:1721405
|
Fukuse T et al. |
Optimal dose of FK 506 in canine lung allotransplantation. |
1992 |
Transplant. Proc. |
pmid:1379757
|
Tanaka M et al. |
Reduction of immunosuppressive agents after living related donor liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8769268
|
Starzl TE et al. |
Liver transplantation: an unfinished product. |
1989 |
Transplant. Proc. |
pmid:2469232
|
Berloco P et al. |
Tacrolimus as cornerstone immunosuppressant in kidney transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267161
|
Shi Y et al. |
Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China. |
|
Transplant. Proc. |
pmid:28104150
|
Alkhunaizi AM et al. |
Breast fibroadenomas in renal transplant recipients. |
2004 Jul-Aug |
Transplant. Proc. |
pmid:15350492
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Alberti D et al. |
Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723310
|
Doesch AO et al. |
Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. |
2010 |
Transplant. Proc. |
pmid:21168673
|
Lim SM et al. |
Heterotopic heart transplantation in the rat receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445080
|
Mohamed MA et al. |
TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267336
|
Alvarez-ElÃas AC et al. |
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. |
2016 |
Transplant. Proc. |
pmid:27110018
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients. |
1999 |
Transplant. Proc. |
pmid:10500604
|
Simmons RL and Wang SC |
New horizons in immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1714645
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|